We are live on
!
Find out more
PTC
Philadelphia Trust Company Portfolio holdings
AUM
$1.42B
1-Year Est. Return
43.77%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$934M
AUM Growth
+$49.6M
(+5.6%)
Cap. Flow
-$30M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
236
New
25
Increased
26
Reduced
87
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$4.52M |
| 2 |
iShares Gold Trust
IAU
|
+$4.42M |
| 3 |
BWX Technologies
BWXT
|
+$4.33M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$4.21M |
| 5 |
iShares US Aerospace & Defense ETF
ITA
|
+$3.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$8.49M |
| 2 |
CVS Health
CVS
|
+$3.83M |
| 3 |
Microsoft
MSFT
|
+$3.59M |
| 4 |
AbbVie
ABBV
|
+$3.27M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.43% |
| 2 | Healthcare | 20.57% |
| 3 | Financials | 14.53% |
| 4 | Industrials | 12.53% |
| 5 | Communication Services | 6.33% |
Similar funds
CBA
BC
KC
EWS
SCM
NI
QC
IHG
Philadelphia Trust Company's Q4 2022 Portfolio in Review
As of Q4 2022, Philadelphia Trust Company held 236 positions worth $934M, up 5.6% from $884M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Philadelphia Trust Company withdrew a net $30M in Q4 2022, closing 13 positions and reducing 87 holdings. Its most notable exit was SPDR Gold Trust, an estimated $8.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Philadelphia Trust Company opened a new position in Qorvo worth $4.53M.
- Philadelphia Trust Company's largest Q4 2022 buy was Qorvo: 50,000 shares worth $4.53M.
- Philadelphia Trust Company added most to JPMorgan Chase in Q4 2022, an estimated $2.98M increase.
- Philadelphia Trust Company's biggest Q4 2022 reduction was CVS Health, cutting an estimated $3.83M.
- Philadelphia Trust Company fully exited SPDR Gold Trust in Q4 2022, selling an estimated $8.49M.
- Philadelphia Trust Company's ten largest holdings make up 35% of its $934M portfolio in Q4 2022.
- Philadelphia Trust Company opened 25 new positions and closed 13 in Q4 2022.
- Philadelphia Trust Company's portfolio value rose 5.6% quarter-over-quarter to $934M.
Based on Philadelphia Trust Company's 13F filing for Q4 2022, filed 7 Feb 2023.